Niche Clinical Trials BATI coordinates cancer prevention trials with a focus on prostate cancer and participates as a site within a large multi-site trial network. This suggests potential partnerships in patient recruitment support, trial logistics, and data management services tailored to prevention and early-stage cancer research.

High Network Potential As one of 400 sites across the US, Canada, and Puerto Rico hosting the SELECT trial, BATI has access to expansive trial networks and potential collaboration opportunities with larger cancer centers for site referrals, patient recruitment pipelines, and shared platform capabilities.

Limited Scale Opportunity With a small team size (2–10 employees) and revenue under one million, BATI represents an opportunity for scalable, cost-effective support services such as cloud-based site management, regulatory support, and outsourced trial administration to extend capacity without significant fixed overhead.

Tech Stack Fit BATI’s technology usage includes cloud and web analytics tools (Google Analytics, Google Search Console), cloudflare services, and standard web servers, indicating openness to digital marketing support, website optimization, and data security enhancements that can improve site visibility and compliance.

Competitive Positioning Operating in the high-stakes cancer research space with peers like City of Hope and Memorial Sloan Kettering, BATI could benefit from partnerships offering trial enrollment acceleration, patient engagement tools, and research operations services that help compete for higher-enrollment sites and secure broader participation in prevention trials.